Cited by 262Multiple Sclerosis Research StudiesTreatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.

Depression in multiple sclerosis

Patten, Scott B., Marrie, Ruth Ann, Carta, Mauro G.·2017·International Review of Psychiatry

DOI 10.1080/09540261.2017.1322555

Open this paper in CoChat — free account

Abstract

Depressive disorders occur in up to 50% of people living with multiple sclerosis (MS). Prevalence estimates are generally 2-3-times higher than those of the general population. Myriad aetiologic factors may contribute to the aetiology of depression in MS including biological mechanisms (e.g. hippocampal microglial activation, lesion burden, regional atrophy), as well as the stressors, threats, and losses that accompany living with an unpredictable and often disabling disease. Some prominent risk factors for depression such as (younger) age, (female) sex, and family history of depression are less consistently associated with depression in MS than they are in the general population. Management of depression in MS has not been well studied, but available data on detection and treatment align with general principles of depression management. While the validity of standard measurement scales has often been questioned, available evidence suggests that standard scales provide valid ratings. Evidence for the effectiveness of depression treatments in MS is limited, but available evidence supports the effectiveness of standard treatment approaches, including both cognitive behavioural therapies and antidepressant medications.

Integrity signals

Registry

Crossref · 10.1080/09540261.2017.1322555

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Validation and Utility of a Self-report Version of PRIME-MD<SUBTITLE>The PHQ Primary Care Study</SUBTITLE>
Spitzer, R. L. (1999) · JAMA · doi:10.1001/jama.282.18.1737 · Cited by 9,802
The Epidemiology of Major Depressive Disorder: Results From the National Comorbidity Survey Replication (NCS-R)
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
The PHQ-9: A New Depression Diagnostic and Severity Measure
Kroenke, K., & Spitzer, R. L. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20020901-06 · Cited by 5,898 · cited 2×
“…samples from clinical settings or volunteer community samples, a recent national survey conducted in Canada used the Brief Patient Health Questionnaire (Kroenke & Spitzer, 2002; Spitzer, Kroenke, Williams, & Group, 1999), or PHQ-9, in a probability sample representative of the household population.”
Method
A Diagnostic Interview
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,697
Screening for Depression in Well Older Adults: Evaluation of a Short Form of the CES-D
Andresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)30622-6 · Cited by 5,403
The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI)
Kessler, R. C., & Üstün, T. B. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.168 · Cited by 4,771
Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale).
Andresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994) · PubMed · Cited by 4,426
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · cited 1×
“Inflammatory changes are implicated in the aetiology of depression generally (Miller & Raison, 2016), providing another set of candidate mechanisms that may link depression to MS (Feinstein et al., 2014).”
Background
The world health organization composite international diagnostic interview short-form (CIDI-SF)
Kessler, R. C., Andrews, G., Mroczek, D., Ustun, B., & Wittchen, H. (1998) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.47 · Cited by 2,242

Show all 103 references

Research works printed but not linked: 7

First M., 1997, Structured clinical interview for DSM-IV Axis I disorders. Research version, non-patient edition (SCID-I/NP)
Goldenberg M.M., 2012, p T, 37, 175
10.1037//0022-006X.69.6.942 · DOI · Paper page
10.1037/0022-006X.68.2.356 · DOI · Paper page
10.1037/0278-6133.18.4.383 · DOI
10.1191/135245800678827536 · DOI
Salehpoor G., 2014, Iranian Journal of Nursing and Midwifery Research, 19, 593

Sorted by citations

The Bidirectional Relationship of Depression and Inflammation: Double Trouble
Beurel, E., Toups, M., & Nemeroff, C. B. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.002 · Cited by 2,136
Major depressive disorder
Marx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00454-1 · Cited by 910
Pragmatism as a paradigm for patient‐oriented research
Allemang, B. A., Sitter, K. C., & Dimitropoulos, G. (2021) · Health Expectations · doi:10.1111/hex.13384 · Cited by 243
Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles
Riazi, A. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.6.710 · Cited by 135
New Insights into the Pivotal Role of the Amygdala in Inflammation-Related Depression and Anxiety Disorder
Hu, P., Lü, Y., Pan, B., & Zhang, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911076 · Cited by 139
Effects of long-term administration of Multi-Strain Probiotic on circulating levels of BDNF, NGF, IL-6 and mental health in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial
Rahimlou, M., Hosseini, S. A., Majdinasab, N., Haghighizadeh, M. H., & Husain, D. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1758887 · Cited by 109
Longitudinal course of depression symptoms in multiple sclerosis
Arnett, P. A. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.047712 · Cited by 107
Smouldering‐Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions
Scalfari, A., Traboulsee, A. L., Oh, J., Airas, L. M., Bittner, S., Calabrese, M., García‐Domínguez, J. M., Granziera, C., Greenberg, B. M., Hellwig, K., et al. (2024) · Annals of Neurology · doi:10.1002/ana.27034 · Cited by 107
Anxiety and depression in patients with multiple sclerosis: The mediating effects of perceived social support
Henry, A., Tourbah, A., Camus, G., Deschamps, R., Mailhan, L., Castex, C., Gout, O., & Montreuil, M. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.09.039 · Cited by 95
The Psychological Impact of COVID-19 Pandemic on People With Multiple Sclerosis
Motolese, F., Rossi, M., Albergo, G., Stelitano, D., Villanova, M., Lazzaro, V. D., & Capone, F. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.580507 · Cited by 93
The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases
Enns, M. W., Bernstein, C. N., Kroeker, K., Graff, L. A., Walker, J. R., Lix, L. M., Hitchon, C. A., El-Gabalawy, R. M., Fisk, J. D., Marrie, R. A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198975 · Cited by 95
Self-citation
miR-155 as an Important Regulator of Multiple Sclerosis Pathogenesis. A Review
Maciak, K., Dziedzic, A., Miller, E. D., & Saluk, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094332 · Cited by 90
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
Bruno, A., Dolcetti, E., Rizzo, F. R., Fresegna, D., Musella, A., Gentile, A., Vito, F. D., Caioli, S., Guadalupi, L., Bullitta, S., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00169 · Cited by 87
Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: A systematic review
Patrick, S., & Connick, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0197943 · Cited by 67
Distinct characteristics of hippocampal pathogenic th17 cells in a mouse model of depression
Beurel, E., Lowell, J. A., & Jope, R. S. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.04.012 · Cited by 65
Depression in multiple sclerosis: Is one approach for its management enough?
Jones, C. D., Motl, R. W., & Sandroff, B. M. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102904 · Cited by 64
Targeting the Adaptive Immune System in Depression: Focus on T Helper 17 Cells
Beurel, E., Medina-Rodriguez, E. M., & Jope, R. S. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000256 · Cited by 60
The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology
Buscarinu, M. C., Fornasiero, A., Romano, S., Ferraldeschi, M., Mechelli, R., Reniè, R., Morena, E., Romano, C., Pellicciari, G., Landi, A. C., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01916 · Cited by 68
Infections in patients with multiple sclerosis: A national cohort study in Sweden
Castelo‐Branco, A., Chiesa, F., Conte, S., Bengtsson, C., Lee, S., Minton, N., Niemcryk, S. J., Lindholm, A., Rosenlund, M., Piehl, F., et al. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102420 · Cited by 60
Chronic fatigue and depression due to multiple sclerosis: Immune-inflammatory pathways, tryptophan catabolites and the gut-brain axis as possible shared pathways
Ormstad, H., Simonsen, C. S., Broch, L., Maes, M. H. J., Anderson, G., & Celius, E. G. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102533 · Cited by 56
Recommendations on Social Determinants of Health in Neurologic Disease
Towfighi, A., Berger, R. P., Corley, A. M. S., Glymour, M. M., Manly, J. J., & Skolarus, L. E. (2023) · Neurology · doi:10.1212/wnl.0000000000207562 · Cited by 59
The role of melatonin in Multiple Sclerosis
Skarlis, C., & Anagnostouli, M. C. (2019) · Neurological Sciences · doi:10.1007/s10072-019-04137-2 · Cited by 56
Modulation of neuroimmune cytokine networks by antidepressants: implications in mood regulation
Nava, R. G., Adri, A. S., Filgueiras, I. S., Nóbile, A. L., Barcelos, P. M., Corrêa, Y. L. G., de Oliveira, S. F., Cabral‐Miranda, G., Dias, H. D., Schimke, L. F., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03532-y · Cited by 53
Identifying risk factors for cognitive issues in multiple sclerosis
Amato, M. P., Prestipino, E., & Bellinvia, A. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1590199 · Cited by 41
MicroRNAs, Multiple Sclerosis, and Depression
Wang, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157802 · Cited by 43
Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis
Menculini, G., Chipi, E., Paoletti, F. P., Gaetani, L., Nigro, P., Simoni, S., Mancini, A., Tambasco, N., Filippo, M. D., Tortorella, A. A. V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094440 · Cited by 44
Depression and anxiety in multiple sclerosis. Review of a fatal combination
Jellinger, K. A. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02792-0 · Cited by 48
Perinatal Depression and Anxiety in Women With Multiple Sclerosis: A Population-Based Cohort Study
Eid, K., Torkildsen, Ø. F., Aarseth, J., Flemmen, H. Ø., Holmøy, T., Lorentzen, Å. R., Myhr, K.-M., Riise, T., Simonsen, C., Torkildsen, C. F., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012062 · Cited by 35
Depressive symptoms in people with disabilities; secondary analysis of cross-sectional data from the United Kingdom and Greece
Rotarou, E. S., & Sakellariou, D. (2017) · Disability and health journal · doi:10.1016/j.dhjo.2017.12.001 · Cited by 33
Mindfulness- and Acceptance-Based Interventions for Symptom Reduction in Individuals With Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Han, A. (2021) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2021.03.011 · Cited by 29
Mental health and chronic diseases: a challenge to be faced from a new perspective
Carta, M. G., Patten, S. B., Nardi, A. E., & Bhugra, D. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1364885 · Cited by 28
Self-citation
Management of multiple sclerosis in older adults: review of current evidence and future perspectives
DiMauro, K. A., Swetlik, C., & Cohen, J. A. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12384-3 · Cited by 29
Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases
Hecker, M., Frahm, N., Bachmann, P., Debus, J. L., Haker, M.-C., Mashhadiakbar, P., Langhorst, S. E., Baldt, J., Streckenbach, B., Heidler, F., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.946351 · Cited by 29
Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2/TLR4 antagonist (+)-naltrexone
Kwilasz, A. J., Todd, L. S., Duran-Malle, J. C., Schrama, A. E. W., Mitten, E. H., Larson, T. A., Clements, M. A., Harris, K. M., Litwiler, S. T., Wang, X., et al. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112896 · Cited by 28
Depression in multiple sclerosis across the adult lifespan
Chan, C. K., Tian, F., Pimentel Maldonado, D., Mowry, E. M., & Fitzgerald, K. C. (2021) · Multiple Sclerosis Journal · doi:10.1177/1352458520979304 · Cited by 26
Risk of depression in multiple sclerosis across disease-modifying therapies
Longinetti, E., Frisell, T., Englund, S., Reutfors, J., Fang, F., & Piehl, F. (2021) · Multiple Sclerosis Journal · doi:10.1177/13524585211031128 · Cited by 26
The effect of therapeutic exercise on depressive symptoms in people with multiple sclerosis – A systematic review
Kyriakatis, G. M., Besios, T., & Lykou, P. M. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104407 · Cited by 26
Clinical Practice Guidelines for the Detection and Treatment of Depression in Multiple Sclerosis
McIntosh, G. E., Liu, E. S., Allan, M., & Grech, L. (2023) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200154 · Cited by 28
Depression in persons with disabilities: a scoping review
Asdaq, S. M. B., Alshehri, S., Alajlan, S. A., Almutiri, A. A., & Alanazi, A. K. R. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1383078 · Cited by 29
Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood Onset
Portaccio, E., Bellinvia, A., Razzolini, L., Pastò, L., Goretti, B., Niccolai, C., Fonderico, M., Zaffaroni, M., Pippolo, L., Moiola, L., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200115 · Cited by 24
Effects of different dietary interventions in multiple sclerosis: a systematic review of evidence from 2018 to 2022
Atabılen, B., & Akdevelıoğlu, Y. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2146843 · Cited by 24
The Impact of Epigallocatechin Gallate and Coconut Oil Treatment on Cortisol Activity and Depression in Multiple Sclerosis Patients
Platero, J. L., Cuerda‐Ballester, M., Sancho-Cantus, D., Benlloch, M., Cerón, J. M. C., Rubio, C. P., García-Pardo, M. P., López‐Rodriguez, M. M., & Ortí, J. E. D. L. R. (2021) · Life · doi:10.3390/life11040353 · Cited by 26
Multiple sclerosis by phenotype in Germany
Engelhard, J., Oleske, D. M., Schmitting, S., Wells, K. E., Talapala, S., & Barbato, L. M. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103326 · Cited by 24
Keeping it together: The role of social integration on health and psychological well‐being among individuals with multiple sclerosis
Latinsky‐Ortiz, E. M., & Strober, L. B. (2022) · Health & Social Care in the Community · doi:10.1111/hsc.13800 · Cited by 27
The Influence of Depression and Anxiety on Neurological Disability in Multiple Sclerosis Patients
Văcăraș, V., Văcăraș, V., Nistor, C., Văcăraș, D., Opre, A. N., Blaga, P., & Muresanu, D. F. (2020) · Behavioural Neurology · doi:10.1155/2020/6738645 · Cited by 23
Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional study
Alirezaei, M., Eskandarieh, S., Sahraian, M. A., & Moghadasi, A. N. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05612-5 · Cited by 22
Predicting Multiple Sclerosis Outcomes During the COVID-19 Stay-at-home Period: Observational Study Using Passively Sensed Behaviors and Digital Phenotyping
Chikersal, P., Venkatesh, S., Masown, K., Walker, E., Quraishi, D. A., Dey, A. K., Goel, M., & Xia, Z. (2022) · JMIR Mental Health · doi:10.2196/38495 · Cited by 20
Pharmacological management of depression in patients with multiple sclerosis
Carta, M. G., Paribello, P., Anastasia, A., Berardis, D. D., Nardi, A. E., & Fornaro, M. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1516207 · Cited by 21
Self-citation
Vitamin B1 Intake in Multiple Sclerosis Patients and its Impact on Depression Presence: A Pilot Study
Ortí, J. E. D. L. R., Cuerda‐Ballester, M., Drehmer, E., Carrera‐Juliá, S., Motos-Muñoz, M., Cunha-Pérez, C., Benlloch, M., & López‐Rodriguez, M. M. (2020) · Nutrients · doi:10.3390/nu12092655 · Cited by 19
Adherence to and Persistence with Disease-Modifying Therapies for Multiple Sclerosis Over 24 Months: A Retrospective Claims Analysis
Pardo, G., Pineda, E. D., Ng, C. D., Bawa, K., Sheinson, D. M., & Bonine, N. G. (2022) · Neurology and Therapy · doi:10.1007/s40120-021-00319-3 · Cited by 19
The manifestation of affective symptoms in multiple sclerosis and discussion of the currently available diagnostic assessment tools
Filser, M., Buchner, A., Fink, G. R., Gold, S. M., & Penner, I. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11359-6 · Cited by 18
Neuro-immune crosstalk in depressive symptoms of multiple sclerosis
Wang, C., Zhou, Y., & Feinstein, A. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106005 · Cited by 20
Cognitive impairment in multiple sclerosis: “classic” knowledge and recent acquisitions
Piacentini, C., Argento, O., & Nocentini, U. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0043-1763485 · Cited by 18
Nogo-A antibody delivery through the olfactory mucosa mitigates experimental autoimmune encephalomyelitis in the mouse CNS
Pernet, V., Joly, S., Spiegel, S., Meli, I., Idriss, S., Maigler, F., Mdzomba, J. B., Roenneke, A. K., Franceschini, A., Silvestri, L., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01588-7 · Cited by 18
Treating depression in clinical practice: new insights on the multidisciplinary use of trazodone
Albert, U., Tomasetti, C., Marra, C., Neviani, F., Pirani, A., Taddeo, D., Zanetti, O. O., & Maina, G. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1207621 · Cited by 18
Non-infectious comorbidity in patients with multiple sclerosis: A national cohort study in Sweden
Castelo‐Branco, A., Chiesa, F., Bengtsson, C., Lee, S., Minton, N., Niemcryk, S. J., Lindholm, A., Rosenlund, M., Piehl, F., & Montgomery, S. (2020) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217320947761 · Cited by 20
Associations of demographic and clinical factors with depression over 2.5-years in an international prospective cohort of people living with MS
Simpson, S., Taylor, K. L., Jelinek, G. A., Livera, A. M. D., Brown, C. R., O’Kearney, E., Neate, S. L., Bevens, W., & Weiland, T. J. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.02.014 · Cited by 18
Possible role of the NLRP3 inflammasome and the gut–brain axis in multiple sclerosis‐related depression
Maciak, K., Dziedzic, A., & Saluk, J. (2022) · The FASEB Journal · doi:10.1096/fj.202201348r · Cited by 18
Interventions to Improve Quality of Life in Multiple Sclerosis: New Opportunities and Key Talking Points
Faraclas, E. (2023) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s395733 · Cited by 17
A Prospective, Observational, Cohort Study to Assess the Efficacy and Safety of Prolonged-Release Fampridine in Cognition, Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients: The FAMILY Study
Mitsikostas, D. D., Doskas, T. K., Gkatzonis, S., Fakas, N., Maltezou, M., Papadopoulos, D., Gourgioti, R., & Mitsias, P. D. (2021) · Advances in Therapy · doi:10.1007/s12325-020-01606-5 · Cited by 17
Multiple Sclerosis and the Endogenous Opioid System
Dworsky-Fried, Z., Chadwick, C. I., Kerr, B. J., & Taylor, A. M. W. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.741503 · Cited by 17
Low‑field magnetic stimulation improved cuprizone‑induced depression‑like symptoms and demyelination in female mice
Mooshekhian, A., Sandini, T. M., Wei, Z., van Bruggen, R., Li, H., Li, X., & Zhang, Y. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11133 · Cited by 16
Serum and CSF Biomarkers Predict Active Early Cognitive Decline Rather Than Established Cognitive Impairment at the Moment of RRMS Diagnosis
Tiu, V. E., Popescu, B. O., Enache, I. I., Tiu, C., Terecoasă, E., & Panea, C. (2022) · Diagnostics · doi:10.3390/diagnostics12112571 · Cited by 17
Clinical correlates of state and trait anxiety in multiple sclerosis
Menculini, G., Gentili, L., Gaetani, L., Mancini, A., Sperandei, S., Sabatino, E. D., Chipi, E., Salvadori, N., Tortorella, A. A. V., Parnetti, L., et al. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104431 · Cited by 18
Pulse steroid therapy in multiple sclerosis and mood changes: An exploratory prospective study
Lorefice, L., Fenu, G., Fois, M., Frau, J., Coghe, G., Marrosu, M. G., & Cocco, E. E. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.01.012 · Cited by 16
Relationship of Motor Impairment with Cognitive and Emotional Alterations in Patients with Multiple Sclerosis
Cuerda‐Ballester, M., Martínez‐Rubio, D., García-Pardo, M. P., Proaño, B., Cubero-Plazas, L., Calvo-Capilla, A., Sancho-Cantus, D., & Ortí, J. E. D. L. R. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021387 · Cited by 15
Effects of crocin on inflammatory biomarkers and mental health status in patients with multiple sclerosis: A randomized, double-blinded clinical trial
Kouchaki, E., Rafiei, H., Ghaderi, A., Azadchehr, M. J., Safa, F., Omidian, K., Khodabakhshi, A., Vahid, F., Rezapoor-Kafteroodi, B., Banafshe, H. R., et al. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105454 · Cited by 17
Factors associated with perceived need for mental health care in multiple sclerosis
Orr, J., Bernstein, C. N., Graff, L. A., Patten, S. B., Bolton, J. M., Sareen, J., Marriott, J. J., Fisk, J. D., & Marrie, R. A. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.07.043 · Cited by 15
Self-citation
The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
Frahm, N., Hecker, M., Langhorst, S. E., Mashhadiakbar, P., Haker, M.-C., & Zettl, U. K. (2020) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286420969501 · Cited by 17
Disability and its association with psychological factors in multiple sclerosis patients
Mohaghegh, F., Moghaddasi, M., Eslami, M., Dadfar, M., & Lester, D. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102733 · Cited by 14
Managing neuropsychological impairment in multiple sclerosis – Controlled study on a standardized metacognitive intervention (MaTiMS)
Pöttgen, J., Friede, T., Lau, S., Gold, S. M., Letsch, C., Bender, G., Flachenecker, P., Heesen, C., & Penner, I. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103687 · Cited by 14
Multiple sclerosis management and reproductive changes
Kaisey, M., Sicotte, N. L., & Giesser, B. S. (2018) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000436 · Cited by 14
Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial
Smyth, P. S., Watson, K. E., & Tsuyuki, R. T. (2021) · Trials · doi:10.1186/s13063-021-05726-3 · Cited by 13
The effect of nurse practitioner (NP-led) care on health-related quality of life in people with multiple sclerosis – a randomized trial
Smyth, P. S., Watson, K. E., Hamarneh, Y. N. A., & Tsuyuki, R. T. (2022) · BMC Neurology · doi:10.1186/s12883-022-02809-9 · Cited by 13
The prevalence of depression and anxiety among Iranian people with multiple sclerosis: A systematic review and meta-analysis.
Shafiee, A., Soltani, H., Athar, M. M. T., Jafarabady, K., & Mardi, P. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104922 · Cited by 13
Reviewing the mitochondrial dysfunction paradigm in rodent models as platforms for neuropsychiatric disease research
van Rensburg, D. J., Lindeque, J. Z., Harvey, B. H., & Steyn, S. F. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.03.002 · Cited by 13
The effectiveness of group intervention focused on intolerance of uncertainty on psychological distress and quality of life in multiple sclerosis patients
Rahimi, H., Pirmoradi, M., Lavasani, F. F., & Farahani, H. (2023) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_521_22 · Cited by 12
“[9] Research has shown that 50% of people with MS have experienced depressive disorder at least once.[10,11]”
Background
Trait mindfulness, emotion dysregulation, and depression in individuals with multiple sclerosis
Duraney, E. J., Schirda, B., Nicholas, J. A., & Prakash, R. S. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103651 · Cited by 13
Bipolar disorders and deep grey matter in multiple sclerosis: A preliminary quantitative MRI study
Lorefice, L., Fenu, G., Carta, E., Frau, J., Coghe, G., Contu, F., Barracciu, M. A., Carta, M. G., & Cocco, E. E. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102564 · Cited by 12
Self-citation
Efficacy of remote exercise and physiotherapy programs on depressive symptoms in people with multiple sclerosis - A systematic review and meta-analysis
Kyriakatis, G. M., Lykou, P. M., Dimitriadis, Z., & Besios, T. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105067 · Cited by 15
Exploring the relationship between disability status, depression, and quality of life in individuals with multiple sclerosis
Asadollahzadeh, E., Ebadi, Z., Owji, M., Rezaeimanesh, N., Sahraian, M. A., & Moghadasi, A. N. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105629 · Cited by 12
Therapeutic effects and mechanisms of fecal microbiota transplantation on EAE partly through HPA axis-mediated neuroendocrine regulation
Xu, D., Ren, L., Zhang, W., Wu, S., Yu, M., He, X., & Wei, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33214 · Cited by 12
The relationship between dimensions of mental health and alexithymia in multiple sclerosis patients
Christopoulos, A. L., Πούλιος, Α., & Pavlopoulos, V. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102525 · Cited by 14
Tunisian version of the brief international cognitive assessment for multiple sclerosis: Validation and normative values
Souissi, A., Mrabet, S., Ferchichi, W., Gharbi, A., Nasri, A., Djebara, M. B., Kacem, I., & Gouider, R. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103444 · Cited by 12
Influence of psychopathological factors and personality traits on the results of the study of quality of life in patients with multiple sclerosis
Vl, M., Boyko, A. N., Konovalova, O. E., Iskandirova, A. S., Dumbrova, E. V., Boyko, O. V., & Malygin, Y. V. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20191192242 · Cited by 11
An Audit of UK Hospital Doctors’ Knowledge and Experience of Myalgic Encephalomyelitis
Hng, K., Geraghty, K., & Pheby, D. (2021) · Medicina · doi:10.3390/medicina57090885 · Cited by 13
Major Depressive Disorder in an International Multisite Wilson Disease Registry
Camarata, M. A., Ala, A., Coskun, A. K., Deng, Y., Embel, V. K., González‐Peralta, R. P., Maciejewski, K. R., Patel, A., Rubman, S., To, U. K., et al. (2022) · Journal of the Academy of Consultation-Liaison Psychiatry · doi:10.1016/j.jaclp.2022.12.001 · Cited by 11
Textbook of Medical Psychiatry
Silbersweig, D., Muskin, P. R., & Querques, J. (2020) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378869 · Cited by 11
Untreated and under-treated depressive symptoms in people with multiple sclerosis in an Australian context: A secondary analysis
Grech, L., Haines, S., Marck, C. H., Hester, R., & Butler, E. G. (2020) · Collegian Journal of the Royal College of Nursing Australia · doi:10.1016/j.colegn.2020.02.010 · Cited by 10
Early depressive symptoms and disability accrual in Multiple Sclerosis: a UK MS Register study
Jacobs, B. M., Daruwalla, C., McKeon, M. O., Al-Najjar, R., Simcock-Davies, A., Tuite-Dalton, K., Brown, J. W. L., Dobson, R., Rodgers, J., & Middleton, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-34545-6 · Cited by 13
Fluvoxamine inhibits Th1 and Th17 polarization and function by repressing glycolysis to attenuate autoimmune progression in type 1 diabetes
Zou, Y., Zhang, J., Sun, F., Xu, Q., Chen, L., Luo, X., Wang, T., Zhou, Q., Zhang, S., Xiong, F., et al. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00791-1 · Cited by 11
Depression in multiple sclerosis patients associated with risk variant near NEGR1
Brugger, S. W., Gardner, M., Beales, J. T., Briggs, F. B. S., & Davis, M. F. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102537 · Cited by 12
How I see is how I feel. Identification of illness perception schema and its association with adaptation outcomes in multiple sclerosis – a 5-year prospective study
Różycka, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258740 · Cited by 12
Association between transition readiness and mental health comorbidity in youth with chronic health conditions
Allemang, B. A., Dimitropoulos, G., Patten, S. B., Sitter, K. C., Brobbey, A., Mackie, A. S., & Samuel, S. M. (2022) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2022.09.012 · Cited by 10
Self-citation
Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis
Riemer, F., Skorve, E., Pasternak, O., Zaccagna, F., Lundervold, A. J., Torkildsen, Ø., Myhr, K., & Grüner, R. (2023) · Communications Medicine · doi:10.1038/s43856-023-00319-4 · Cited by 9
Associated Psychological Disorders and Impairment of Emotional Regulation among Patients with Multiple Sclerosis
Andreeva, M. T., & Караваева, Т. А. (2020) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2019-4-2-19-28 · Cited by 11
Explanatory factors of balance confidence in persons with multiple sclerosis: Beyond the physical functions
Abasıyanık, Z., Özdoğar, A. T., Sağıcı, Ö., Kahraman, T., Baba, C., Ertekin, Ö., & Özakbaş, S. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102239 · Cited by 10
Association of depression in multiple sclerosis with fatigue, sleep disturbances, disability, and health-related quality of life: Outcomes of a cross-sectional study
Aparicio-Castro, E., Candeliere-Merlicco, A., Santa, C. M., & Villaverde, R. (2024) · Neurology Perspectives · doi:10.1016/j.neurop.2024.100181 · Cited by 10
Genome-wide Mendelian randomization mapping the influence of plasma proteome on major depressive disorder
Li, C., Zhang, K., & Zhao, J. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.01.140 · Cited by 9
Depression, sexual dysfunction, life satisfaction and marriage satisfaction in women with multiple sclerosis
Aydın, T., & Önger, M. E. (2022) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-022-00501-w · Cited by 10

Authors: Patten, S. B., Marrie, R. A., & Carta, M. G.
Affiliations: University of Calgary (CA)
University of Manitoba (CA)
University of Cagliari (IT)
Corresponding author: Patten, Scott B.
ORCID: Patten, Scott B.
Marrie, Ruth Ann
Carta, Mauro G.
Venue: International Review of Psychiatry
Publisher: Informa UK Limited
Published: 2017-07-06
Volume: 29
Issue: 5
Pages: 463-472
ISSN: 0954-0261 (ISSN-L)
1369-1627
DOI: 10.1080/09540261.2017.1322555
OpenAlex: W2726625509
Cited by: 262
References: 103
Citations by year: 2026: 16 · 2025: 22 · 2024: 34 · 2023: 33 · 2022: 43 · 2021: 34 · 2020: 57 · 2019: 11 · 2018: 7 · 2017: 2
FWCI: 3.36
Type: journal article
Language: en
Open access: closed
Locations: International Review of Psychiatry (publishedVersion)
PubMed (publishedVersion)
UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion, public-domain)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords: depression, multiple sclerosis, prevalence, etiology, lesion burden, brain atrophy, stressors, risk factors, depression screening, depression treatment, cognitive behavioral therapy, antidepressants, measurement scales
MeSH terms: Adult, Antidepressive Agents, Depression, Female, Humans, Male, Multiple Sclerosis, Brief Psychiatric Rating Scale, Cognitive Behavioral Therapy, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Depression in multiple sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks